Aptorum Group Limited (APM) experienced a dramatic price increase from $2.36 to $7.42. in a single day. With a massive spike in Volume-2.9 million shares traded vs. the usual 48,000-APM's stock is currently considered overbought. This surge is linked to successful Phase 1 cancer drug trials, sparking investor optimism. Analsys predict a price target of $80, and Connecticut's biotech scene is gaining attention. #APM #Aptorum #BioPharma #Stock #Price #Share #Topnavs #TheRealTopnavs #youtube
browny_440 : eyes on CYN today
TopNavs OP browny_440 : Best of luck! If anyone else sees this account, Block it. Browny is a comment bot.
TopNavs OP : Why Connecticut is Linked to APM